Vaccines Articles
Researchers at the Scripps ResearchInstitute in La Jolla, Calif., have developed a vaccine that may one day protect people against the addictive effects of nicotine.
The U.S. Food and Drug Administration has approved Fluarix Quadrivalent to immunize children ages 3 and older and adults against flu virus subtypes A and B.
According to two recent studies, the flu vaccine may cut the risk of a heart attack or stroke by up to 50 percent.
CSL Biotherapies, a subsidiary of CSL Limited, has won a supply contract for pre-pandemic and pandemic vaccine antigens and related services to theU.S. national stockpile from the U.S.Department of Health and Human Services.
Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data presented by researchers at the Kimmel Cancer Center at Jefferson.
Researchers have concluded a Phase II study of an investigational vaccine against group B Neisseria meningitidis, which shows promising results.
Researchers tested a third dose of the measles-mumps-rubella vaccine on students in an affected community in an effort to control the outbreak.
Despite only 29 human cases of the new strain of swine flu in the past two years, the Centers for Disease Control and Prevention (CDC) is preparing an H3N2 candidate vaccine, and clinical trials are being planned for this year.
Researchers at the University ofBritish Columbia (UBC) have found that the swine flu vaccine triggers antibodies that protect against many flu viruses, including the lethal bird flu strain.
New research suggests it might someday be possible to create a vaccine that could protect a growing fetus from premature birth and related complications.
Recent studies of the flu virus are bringing hope that seasonal flu vaccines will be replaced with long-lasting universal vaccines.
A synthetic vaccine based on nanotechnology may halt autoimmune diseases such as Crohn’s and rheumatoid arthritis.